Novozymes Biopharma DK A/S — Credit Rating and Financial Key Figures

Novozymes Biopharma DK A/S (CVR number: 29603537) is a company from GLADSAXE. The company recorded a gross profit of 12.8 mDKK in 2024. The operating profit was 12.8 mDKK, while net earnings were 11.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was 28.1 %, which can be considered excellent and Return on Equity (ROE) was 24.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 78.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Novozymes Biopharma DK A/S's liquidity measured by quick ratio was 4.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.